4//SEC Filing
Holmes David A 4
Accession 0001104659-10-055361
CIK 0000744962other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 6:03 AM ET
Size
15.8 KB
Accession
0001104659-10-055361
Insider Transaction Report
Form 4
NUTRITION 21 INCNXXI
Holmes David A
10% Owner
Transactions
- Purchase
Common Stock
2010-11-02$0.01/sh+3,725,719$55,886→ 18,725,719 total(indirect: By Pharmachem Laboratories, Inc.) - Purchase
Convertible Preferred Shares Series J 8%
2010-11-02$281.37/sh+3,000$844,110→ 21,193,230 total(indirect: By Pharmachem Laboratories, Inc.)Exercise: $1.22→ Common Stock (2,467,511 underlying) - Purchase
Warrants
2010-11-02+1,134,966→ 22,328,196 total(indirect: By Pharmachem Laboratories, Inc)Exercise: $1.22From: 2008-03-11Exp: 2013-03-11→ Common Stock (1,134,966 underlying) - Purchase
Warrants
2010-11-02+777,778→ 23,105,974 total(indirect: By Pharmachem Laboratories, Inc)Exercise: $2.20From: 2008-03-11Exp: 2013-03-11→ Common Stock (777,778 underlying)
Footnotes (8)
- [F1]The securities reported herein (the "Securities") are owned by Pharmachem Laboratories, Inc.
- [F2]The Securities may be deemed to be indirectly beneficially owned by David A. Holmes under Rule 16a-1(a)(2)(iii), since David Holmes is the controlling shareholder of Pharmachem Laboratories, Inc.
- [F3]Anytime after September 10, 2007.
- [F4]According to the Certificate of Amendment of the Certificate of Designation of the Company which creates the Series J 8% Convertible Preferred Stock and was filed with the Securities Exchange Commission on September 12, 2007, the preferred shares are convertible at any time at the option of the holder. Additionally, on the fourth anniversary of the issue date, the Company shall redeem the then outstanding Preferred Stock.
- [F5]This Number Includes (i) 15,000,000 Shares of Common Stock held directly by the Reporting Person; (ii) 3,725, 719 shares of Common Stock acquired By Pharmachem Laboratories, Inc. and indirectly beneficially owned by the reporting person, and (iii) 2,467,511 shares of Common Stock which may be issued by Nutrition 21, Inc. upon conversion of 3,000 shares of Series J8% Convertible Preferred and deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1)(i) of the Securities and Exchange Act of 1934, as amended.
- [F6]This Number Includes (i) 15,000,000 Shares of Common Stock held directly by the Reporting Person; (ii) 3,725, 719 shares of Common Stock acquired By Pharmachem Laboratories, Inc. and indirectly beneficially owned by the reporting person, (iii) 2,467,511 shares of Common Stock which may be issuable by Nutrition 21, Inc. upon conversion of 3,000 shares of Series J8% Convertible Preferred and deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1)(i) of the Securities and Exchange Act of 1934, as amended (the "Act"), and (iv) 1,134,966 shares of Common Stock issuable by Nutrition 21, Inc. upon exercise of the warrants and deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1)(i) of the Act.
- [F7]This Number Includes (i) 15,000,000 Shares of Common Stock held directly by the Reporting Person; (ii) 3,725, 719 shares of Common Stock acquired By Pharmachem Laboratories, Inc. and indirectly beneficially owned by the reporting person, (iii) 2,467,511 shares of Common Stock which may be issuable by Nutrition 21, Inc. upon conversion of 3,000 shares of Series J8% Convertible Preferred and deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1)(i) of the Securities and Exchange Act of 1934, as amended (the "Act"), (iv) 1,134,966 shares of Common Stock issuable by Nutrition 21, Inc. upon exercise of the warrants and deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1)(i) of the Act, and (v) 777,778 shares of Common Stock issuable by Nutrition 21, Inc. upon exercise of the warrants and deemed beneficially owned by the Reporting Person pursuant to Rule 13d-3(d)(1)(i) of the Act.
- [F8]No price was given to the warrants as they were attached to the Convertible Preferred Shares Series J 8%.
Documents
Issuer
NUTRITION 21 INC
CIK 0000744962
Entity typeother
Related Parties
1- filerCIK 0001498510
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 6:03 AM ET
- Size
- 15.8 KB